ArticleCellular and molecular life sciences : CMLS2024

Targeting NG2 relieves the resistance of BRAF-mutant thyroid cancer cells to BRAF inhibitors.

Fang Sui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.